↓ Skip to main content

Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia

Overview of attention for article published in BMC Infectious Diseases, March 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy
1 policy source
twitter
4 tweeters

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Published in
BMC Infectious Diseases, March 2014
DOI 10.1186/1471-2334-14-172
Pubmed ID
Authors

Jaime E Ordóñez, John J Orozco

Abstract

Nowadays, there are two vaccination strategies in Colombia to prevent pneumococcal diseases in people over 50 years. Our aim is to estimate cost-effectiveness of pneumococcal conjugate vaccine 13-valent (PCV13) versus pneumococcal polysaccharide vaccine 23-valent (PPSV23) to prevent pneumococcal diseases and their related mortality in people over 50 years old in Colombia.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Portugal 1 1%
Unknown 71 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 23%
Student > Master 8 11%
Student > Ph. D. Student 8 11%
Student > Bachelor 8 11%
Student > Doctoral Student 4 5%
Other 16 22%
Unknown 12 16%
Readers by discipline Count As %
Medicine and Dentistry 24 33%
Economics, Econometrics and Finance 10 14%
Social Sciences 5 7%
Nursing and Health Professions 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 10 14%
Unknown 16 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2019.
All research outputs
#4,241,208
of 17,349,416 outputs
Outputs from BMC Infectious Diseases
#1,167
of 6,152 outputs
Outputs of similar age
#44,567
of 197,764 outputs
Outputs of similar age from BMC Infectious Diseases
#2
of 13 outputs
Altmetric has tracked 17,349,416 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,152 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 197,764 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.